Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT05187650

Effectiveness of a Powered Exoskeleton Combined With FES for Patients With Chronic SCI: a RCT

Led by Mario Widmer · Updated on 2025-12-18

34

Participants Needed

1

Research Sites

302 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

While there are a number of prospective studies evaluating powered exoskeletons in SCI patients, to date, not a single well-designed, randomized clinical trial has been published. However, there is evidence for beneficial effects of over-ground exoskeleton therapy on walking function post-intervention from a meta-analysis on non-randomized, uncontrolled studies. Functional electrical stimulation (FES), on the other hand, is a common and established method for the rehabilitation of persons with SCI and has been demonstrated to be beneficial in, e.g., improving muscle force, power output and endurance. Combining FES and overground robotic therapy within the same therapy session could potentially merge and potentiate the effects of each separate treatment, making it a very powerful and efficient therapy method. Up to date, however, comparative studies evaluating benefits of this combined approach (i.e., powered exoskeleton and FES) to robotic therapy without FES are missing.

CONDITIONS

Official Title

Effectiveness of a Powered Exoskeleton Combined With FES for Patients With Chronic SCI: a RCT

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Chronic, incomplete spinal cord injury for more than 1 year with AIS B-D classification
  • Traumatic or non-traumatic spinal cord lesion
  • Ability to stand up and perform a 10-meter walk test with or without medical aids
  • Partially dependent on a wheelchair
  • Intact lower motor neurons at specific muscle segments to allow stimulation with FES
Not Eligible

You will not qualify if you...

  • Body weight over 100 kg, height less than 155 cm or over 190 cm, pelvic width over 46 cm
  • Orthopedic issues such as acute lower limb fractures
  • Joint contractures
  • Heterotrophic ossification
  • Spasticity greater than 3 on the modified Ashworth Scale
  • Skin injuries on lower limbs where the exoskeleton contacts the skin
  • Unstable circulation preventing standing for at least 10 minutes
  • Acute deep vein thrombosis
  • Pregnancy (tested in women aged 15 to 49 years)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Swiss Paraplegic Centre

Nottwil, Canton of Lucerne, Switzerland, 6207

Actively Recruiting

Loading map...

Research Team

M

Mario Widmer, PhD

CONTACT

I

Ines Bersch, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here